Aduro Clean Technologies announced a non‑binding Memorandum of Understanding with a leading global Engineering, Procurement, and Construction (EPC) firm to develop a commercial licensing package for its Hydrochemolytic™ Technology (HCT). The partnership will combine Aduro’s chemistry and process know‑how with the EPC’s engineering and project‑delivery expertise to create a pre‑engineered, modular plant concept that can be licensed to customers worldwide.
The MOU is part of Aduro’s broader strategy to shift from a purely technology‑development model to a licensing model that can accelerate commercialization while limiting capital exposure. By partnering with an experienced EPC, Aduro can leverage proven plant design and delivery capabilities, reduce technical and delivery risk, and shorten the time required for customers to bring HCT‑based facilities online.
Aduro’s CEO Ofer Vicus said the agreement “is an important step in the commercialisation roadmap for Hydrochemolytic™ Technology. Aduro has been clear that licensing is one of the key channels in its go‑to‑market strategy, and this MOU supports that direction. Working with a leading global EPC company helps translate HCT into a commercial licence package and a repeatable plant concept that customers can evaluate as an industrial project. The NGP pilot plant has recently transitioned to operating campaigns, and site selection for the FOAK industrial plant has been finalized.”
The first commercial plant under the licensing model is targeted for the Chemelot Industrial Park in the Netherlands, a major European chemical hub that offers integrated infrastructure and a strong customer base. The FOAK plant will have an initial processing capacity of about 10,000 tonnes per year, providing a real‑world demonstration of the technology’s scalability.
Aduro’s financial performance in the six months ended November 30, 2025, shows a 222% year‑over‑year increase in revenue to $122,706 and an 80% year‑to‑date increase to $167,206, but the company remains in a growth‑investment phase with a Q2 loss from operations of $6.46 million and a year‑to‑date loss of $12.79 million. The company has raised approximately $20 million after November 30, 2025, to fund its demonstration plant program and research and development, underscoring its focus on scaling the technology while maintaining a lean balance sheet.
The licensing model is expected to unlock future revenue streams once customers commit to building HCT‑based facilities, providing Aduro with a recurring income stream that complements its current evaluation‑program revenue. The partnership also positions Aduro to capture a share of the growing advanced chemical‑recycling market, which is estimated to be substantial as demand for circular solutions for mixed plastic waste, heavy crude upgrading, and renewable oil conversion increases.
Overall, the MOU represents a strategic milestone that could accelerate Aduro’s path to commercial deployment, reduce execution risk, and create a scalable, repeatable licensing framework that aligns with the company’s long‑term growth objectives.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.